Health, Longevity & Biohacking
Rothblatt says FDA cleared United Therapeutics xeno-heart trial, predicts approval after 50 patients
Peter Diamandis
Martine Rothblatt: Growing Unlimited Organs, AI Consciousness, & Digital Personhood by 2030 | EP#290
What was said
"So now the FDA said based on that you guys go ahead and do a full-blown clinical trial allowed us to go straight to a phase three or phaseless clinical trial. So after 50 patients in the xeno heart clinical trial we should have FDA approval to create an unlimited supply of xeno hearts."
Martine Rothblatt says the US FDA has authorised United Therapeutics to run a xenotransplant heart clinical trial and allowed a “phase three or phaseless” approach. She also claims two earlier patients lived for more than 60 days with the company’s xeno-hearts, and predicts FDA approval could follow after 50 trial patients.
Verification status
Attributed speaker claim
Egleze verified who said this and where. The underlying claim has not been independently established by Egleze.
Source and context
Egleze verified who said this and where. The underlying claim has not been independently established by Egleze.
- Speaker
- Martine Rothblatt · guest
- Programme
- Peter Diamandis
- Episode
- Martine Rothblatt: Growing Unlimited Organs, AI Consciousness, & Digital Personhood by 2030 | EP#290
- Clip time
- 24:29
- Original source
- Watch the source segment →
From this episode
Peter Diamandis